Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page
- Check7 days agoChange DetectedThe website has updated the intervention details to include a verified status by Aiping Zhou and contact information, while also removing the previous intervention type and revision details.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check42 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check57 days agoChange DetectedThe website has added new features while removing several elements related to study data downloads and participant information.SummaryDifference5%
- Check72 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading study data in various formats, while the previous version v2.12.1 has been removed.SummaryDifference5%
- Check79 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.